Medicamen Biotech informs about updates

12 Aug 2022 Evaluate
Medicamen Biotech has informed that MBL has entered into long term agreement with Vital Pharma Nordic, a Denmark based company, for CDMO for multiple products. Vital Pharma Nordic is led by highly experienced specialists and engaged in licensing, development, distribution and sales of specialty Gx pharmaceuticals. VPN operate in the Nordic region now expanding internationally.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

495.05 14.50 (3.02%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.